Citadel Advisors’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-47,731
Closed -$1.42M 9001
2014
Q3
$1.24M Sell
47,731
-269,631
-85% -$7.74M ﹤0.01% 3443
2014
Q2
$10.5M Sell
317,362
-38,868
-11% -$1.12M 0.01% 1234
2014
Q1
$10.7M Buy
356,230
+318,639
+848% +$11M 0.01% 1216
2013
Q4
$1.14M Buy
37,591
+16,106
+75% +$444K ﹤0.01% 3099
2013
Q3
$684K Buy
21,485
+20,275
+1,676% +$465K ﹤0.01% 3491
2013
Q2
$18K Buy
+1,210
New +$16.8K ﹤0.01% 6106

Other funds holding NPSP

Citadel Advisors's NPSP Position: Q4 2014 in Review

Citadel Advisors sold out of NPS PHARMACEUTICALS INC (NPSP) in Q4 2014, closing a stake of 47,731 shares — an estimated $1.42M sold.

Citadel Advisors first reported a position in NPSP in Q2 2013 and held it in 6 quarters. The position peaked at $10.7M in Q1 2014. 213 funds tracked by Wall St. Rank hold NPSP as of Q4 2014.

  • Citadel Advisors reported no remaining NPS PHARMACEUTICALS INC position as of Q4 2014 after selling out during the quarter.
  • Citadel Advisors sold 47,731 NPS PHARMACEUTICALS INC shares in Q4 2014, an estimated $1.42M.
  • Citadel Advisors first reported a position in NPS PHARMACEUTICALS INC in Q2 2013 and held it in 6 quarters.
  • Citadel Advisors's NPS PHARMACEUTICALS INC position peaked at $10.7M in Q1 2014.
  • 213 funds tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q4 2014.

Based on Citadel Advisors's 13F filing for Q4 2014, filed 17 Feb 2015.